Clinical Trial Update: Efficacy, Safety and Tolerability of Aclidinium Bromide/Formoterol Fumarate Compared With Aclidinium Bromide and Formoterol Fumarate in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing the fixed-dose combination aclidinium bromide/formoterol fumarate to the individual components (aclidinium bromide and formoterol fumara…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Aclidinium bromide (Aclidinium bromide)
• Aclidinium bromide/formoterol fumarate (Aclidinium bromide/formoterol fumarate)
• FORMOTEROL FUMARATE (Formoterol fumarate dihydrate)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED | Results posted: 2017-03-23